Effects Oral Agents Vitamine D On COPD

Not Applicable

• Conditions: Condition 1: Severe and very severe COPD. Condition 2: Added at 2012-08-07: chronic obstructive pulmonary diseases.; Chronic obstructive pulmonary diseases; Added at 2012-08-07: Added at 2

• Registration Number: IRCT2012071810332N1
• Lead Sponsor: Khorramabad Univercity Of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

Inclusioncriteria:COPD patients with FEV1/FVC<0/7 and FEV1<50%;negative past medical history of vitamines D disorders
exclusion criteria:positive past medical history of vitamine D disorders

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
FEV1. Timepoint: Before intervention and after intervention. Method of measurement: Spirometery(PFT).

Secondary Outcome Measures

Name	Time	Method
COPD Exacerbation. Timepoint: Before and mean and afterof intervention. Method of measurement: Physical exam.